LinkedIn Profile

Access StemPar Sciences historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:stemparsciences 3124297 Jun 3rd, 2019 12:00AM StemPar Sciences 14 1.00 Open Biotechnology Jun 3rd, 2019 12:31PM Jun 3rd, 2019 12:31PM StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage. Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer. Open Health Care Equipment & Services
private:stemparsciences 3124297 Mar 23rd, 2018 12:00AM StemPar Sciences 16 1.00 Open Biotechnology Mar 23rd, 2017 10:51AM Mar 23rd, 2017 10:51AM StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage. Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer. Health Care Equipment & Services
private:stemparsciences 3124297 Feb 17th, 2018 12:00AM StemPar Sciences 16 1.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage. Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer. Health Care Equipment & Services
private:stemparsciences 3124297 Feb 16th, 2018 12:00AM StemPar Sciences 16 1.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage. Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer. Health Care Equipment & Services
private:stemparsciences 3124297 Feb 15th, 2018 12:00AM StemPar Sciences 16 1.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage. Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer. Health Care Equipment & Services
private:stemparsciences 3124297 Feb 14th, 2018 12:00AM StemPar Sciences 16 1.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage. Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer. Health Care Equipment & Services
private:stemparsciences 3124297 Feb 13th, 2018 12:00AM StemPar Sciences 16 1.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage. Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer. Health Care Equipment & Services
private:stemparsciences 3124297 Feb 12th, 2018 12:00AM StemPar Sciences 16 1.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage. Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer. Health Care Equipment & Services
private:stemparsciences 3124297 Feb 11th, 2018 12:00AM StemPar Sciences 16 1.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage. Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer. Health Care Equipment & Services
private:stemparsciences 3124297 Feb 10th, 2018 12:00AM StemPar Sciences 16 1.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM StemPar is developing powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy- and radiation-induced DNA damage. Important differences in the metabolic pathways of malignant and healthy cells render cancer cells vulnerable to new modes of attack. We have concentrated our efforts on this emerging area of cancer metabolism by exploiting a metabolic pathway that is disrupted in many major types of cancer. Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.